Drug Type Small molecule drug |
Synonyms MTR-104, MTR-105, MTR-106 + [6] |
Target |
Mechanism NOS inhibitors(Nitric oxide synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date (01 Jan 1997), |
Regulation- |
Molecular FormulaC7H19N2O4PS |
InChIKeyCSYSULGPHGCBQD-UHFFFAOYSA-N |
CAS Registry21704-46-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | S-ethylisothiouronium diethylphosphate | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cluster Headache | - | - | 01 Jan 1997 |
Hypotension | - | - | 01 Jan 1997 |
Migraine Disorders | - | - | 01 Jan 1997 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dialysis hypotension | Phase 2 | IL | 01 May 2006 | |
Kidney Failure, Chronic | Phase 2 | IL | 01 May 2006 |